Turning Point Therapeutics, Inc. Proceeds from Common Stock Issued
Turning Point Therapeutics, Inc. reported Proceeds from Common Stock Issued of $351.60 million for the 1-month period ending 2020-05-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2021-03-01
- Turning Point Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2020-03-31 was $25.00K, a 13.64% increase year-over-year.
- Turning Point Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2019-03-31 was $22.00K.
- Turning Point Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2019 was $1.34M, a 1661.84% increase from fiscal 2018.
- Turning Point Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2018 was $76.00K, a 20.63% increase from fiscal 2017.
- Turning Point Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2017 was $63.00K.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|
| 2020-05-31 | $351.60M 10-K · filed 2021-03-01 | ||
| 2020-03-31 | $25.00K 10-Q · filed 2020-05-12 | ||
| 2019-12-31 | $1.34M 10-K · filed 2020-03-18 | ||
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-12 | ||
| 2018-12-31 | $76.00K 10-K · filed 2020-03-18 | ||
| 2017-12-31 | $63.00K 10-K · filed 2020-03-18 |